Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2--a review. (Q38163432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m2--a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Wei-Jei Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yi-Chih Lee

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Anton Cheng

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

148-158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11695-013-1112-y

1 March 2020

exact match

0 references

cites work

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

What matters in ADVANCE and ADVANCE-ON.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index <35 kg/m2: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Outcome after gastrectomy in gastric cancer patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Italian Group for Lap-Band System: results of multicenter study on patients with BMI < or =35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Outcomes of bariatric surgery in patients with body mass index <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic adjustable gastric banding for patients with body mass index of <or=35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Perioperative outcomes of laparoscopic adjustable gastric banding in mildly obese (BMI < 35 kg/m2) compared to severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI<30 kg/m2 (LBMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Type 2 diabetes in obese patients with body mass index of 30-35 kg/m2: sleeve gastrectomy versus medical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Initial results with sleeve gastrectomy for patients with class I obesity (BMI 30-35 kg/m2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic sleeve gastrectomy for mildly obese patients (Body Mass Index of 30 <35 kg/m²): operative outcome and short-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Metabolic intestinal bypass surgery for type 2 diabetes in patients with a BMI <35 kg/m2: comparative analysis of 16 patients undergoing either BPD, BPD-DS, or RYGB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Ileal interposition with sleeve gastrectomy for control of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index <35 kg/m2. A cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Effect of laparoscopic Roux-en-Y gastroenterostomy with BMI<35 kg/m(2) in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-013-1112-Y

Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with One Anastomosis Gastric Bypass.

21 January 2018

1 reference

12 December 2020

Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2

1 reference

12 December 2020

Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.

1 reference

12 December 2020

Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India

1 reference

12 December 2020

Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2

1 reference

12 December 2020

Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes.

1 reference

12 December 2020

Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results

1 reference

12 December 2020

Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus

1 reference

12 December 2020

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment

1 reference

12 December 2020

Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases

1 reference

12 December 2020

Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database

1 reference

12 December 2020

10.1007/S11695-013-1112-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242843%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference